InDevR is a global leader in progressive new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include our VaxArray portfolio of our game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.
Location: United States, Colorado, Boulder
Employees: 51-200
Total raised: $16M
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Adjuvant C... | adjuvantca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.01.2023 | Series B | $9M | - |
| 12.09.2019 | Series A | $7M | - |
Mentions in press and media 9
| Date | Title | Description |
| 11.02.2025 | Revolutionizing Raw Material QC Analytics in Cell and Gene Therapy Manufacturing with Multiplexed Microarray Technology, Upcoming Webinar Hosted by Xtalks | www.indevr.com In this free webinar, discover how multiplexed, microarray-based technology is transforming cell and gene therapy (CGT) manufacturing by streamlining raw material quality control. Attendees will explore how this innovative ap... |
| 22.01.2025 | Revolutionizing mRNA Analytics: Rapid Quantification for Multivalent Vaccine Development, Upcoming Webinar Hosted by Xtalks | www.indevr.com In this free webinar, learn about an innovative platform that can support rapid and reliable mRNA analytics in diverse applications. Attendees will learn how the VaxArray Platform streamlines the identification and measuremen... |
| 30.09.2024 | Measuring Intact mRNA and 5' Capping Efficiency in One Assay, Upcoming Webinar Hosted by Xtalks | www.indevr.com In this free webinar, learn how a multiplexed imaging platform can be used to determine mRNA capping and address mRNA vaccine drug product characterization requirements. Attendees will gain insights into rapidly measuring int... |
| 26.06.2024 | Streamline Serological Testing Using Multiplexed Assays that Generate Multiple Results in a Single Test, Upcoming Webinar Hosted by Xtalks | www.indevr.com In this free webinar, learn about a unique platform for serological testing that streamlines validated analytical assays with faster, more reliable results. Attendees will be introduced to the VaxArray Platform and its key ad... |
| 18.01.2023 | InDevR raises $9 Million in Series B Financing and Partners with bioMérieux | Boulder, Colorado, United States InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, an... |
| 01.07.2021 | InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization | BOULDER, Colo., July 1, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability ... |
| 12.09.2019 | InDevR Raises $7M Series A Financing | BOULDER, CO, InDevR today announced that it has raised a $7 million Series A round. >> Click here for more funding data on InDevR >> To export InDevR funding data to PDF and Excel, click here InDevR, a biotechnology compa... |
| 10.09.2019 | InDevR Raises $7M in Series A Financing | InDevR, Inc., a Boulder, CO-based biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, raised $7m in Series A round of equity financing. Adjuvant Capi... |
| - | InDevR | “A team of researchers at USAMRIID presented a poster at […]” |